Abstract
Purpose
The new β2 radioligand (R,R)(S,S) 5-(2-(2-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([18F]FE-fenoterol; [18F]FEFE), a fluoroethylated derivative of racemic fenoterol, was evaluated in vivo and ex vivo using a guinea pig model.
Methods
Dynamic PET studies over 60 min with [18F]FEFE were performed in nine Hartley guinea pigs in which a baseline (group 1, n=3), a predose (group 2, n=3; 2 mg/kg fenoterol 5 min prior to injection of [18F]FEFE) or a displacement study (group 3, n=3; 2 mg/kg fenoterol 5 min post injection of [18F]FEFE) was conducted.
Results
In all animal groups, the lungs could be visualised and semi-quantified separately by calculating uptake ratios to non-specific binding in the neck area. Premedication with non-radioactive fenoterol and displacement tests showed significant reduction of lung uptake, by 94% and 76%, respectively.
Conclusion
These data demonstrate specific binding of the new radioligand to the pulmonary β2-receptors in accordance with ex vivo measurements. Therefore, [18F]FEFE seems to be suitable for the in vivo visualisation and quantification of the pulmonary β2-receptor binding in this animal model.
References
O’Byrne PM, Postma DS. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med 1999;159:41–63
Katsunuma T, Fujita K, Mak JC, Barnes PJ, Ueno K, Iikura Y. Beta-adrenergic agonists and bronchial hyperreactivity: role of beta2-adrenergic and tachykinin neurokinin-2 receptors. J Allergy Clin Immunol 2000;106:104–8
Visser TJ, van Waarde A, Doze P, Elsinga PH, van der Mark TW, Kraan J, et al. Characterisation of beta2-adrenoceptors, using the agonist [11C]formoterol and positron emission tomography. Eur J Pharmacol 1998;361:35–41
Moresco RM, Matarrese M, Soloviev D, Simonelli P, Rigamonti M, Gobbo C, et al. Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective beta2-adrenergic radioligand. Int J Pharm 2000;204:101–9
Van Waarde A, Elsinga PH, Brodde OE, Visser GM, Vaalburg W. Myocardial and pulmonary uptake of S-1′-[18F]fluorocarazolol in intact rats reflects radioligand binding to beta-adrenoceptors. Eur J Pharmacol 1995;272:159–68
Schirrmacher E, Schirrmacher R, Thews O, Dillenburg W, Helisch A, Wessler I, et al. Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([18F]FEFE) for the in vivo visualisation and quantification of beta2-adrenergic receptor status in lung. Bioorg Med Chem Lett 2003;13:2687–92
Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992;16:804–13
Carswell H, Nahorski SR. Beta-adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies. Br J Pharmacol 1983;79:965–71
Helisch A, Thews O, Buchholz HG, Schreiber W, Karg A, Vaupel P, et al. Small animal imaging with a conventional PET scanner: application of partial volume correction validated with ex vivo measurements. Eur J Nucl Med Mol Imaging 2002;29:138P
MaloneyHuss K, Lybrand TP. Three-dimensional structure for the beta-2 adrenergic receptor protein based on computer modeling studies. J Mol Biol 1992;225:859–71
Acknowledgements
This study was supported by the German Research Foundation (DFG grant FOR 474). Additionally, the authors thank Boehringer Ingelheim Pharma, Germany, for providing (R,R)(S,S)-fenoterol hydrobromide. Studies had previously been approved by the regional ethics committee and were conducted according to the German Law for Animal Protection.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Helisch, A., Schirrmacher, E., Thews, O. et al. Demonstration of pulmonary β2-adrenergic receptor binding in vivo with [18F]fluoroethyl-fenoterol in a guinea pig model. Eur J Nucl Med Mol Imaging 32, 1324–1328 (2005). https://doi.org/10.1007/s00259-005-1914-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-005-1914-9